Diabetes giant Novo said to consider up to 3,000 layoffs as US pricing storms gather: report
“Uncertain and unpredictable markets” are forcing Novo Nordisk to consider dropping its longterm financial target and cutting 3,000 jobs from its global workforce, according to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.